Schedule of Segment Reporting Information, by Segment [Table Text Block] |
The accounting policies of the segments are the same as those described in the Summary of Significant Accounting Policies. Year Ended June 30, 2017 (in thousands) | | iBio, Inc. | | iBio CDMO | | Eliminations | | Total | | | | | | | | | | | | | | | | Revenues - external customers | | $ | 271 | | $ | 123 | | $ | - | | $ | 394 | | Revenues - intersegment | | | 972 | | | 1,280 | | | (2,252) | | | - | | Research and development | | | 3,657 | | | 1,763 | | | (1,303) | | | 4,117 | | General and administrative | | | 5,245 | | | 6,255 | | | (949) | | | 10,551 | | Operating loss | | | (7,659) | | | (6,615) | | | - | | | (14,274) | | Interest expense | | | (1) | | | (1,928) | | | - | | | (1,929) | | Interest and other income | | | 43 | | | 21 | | | - | | | 64 | | Consolidated net loss | | | (7,617) | | | (8,522) | | | - | | | (16,139) | | Total assets | | | 19,049 | | | 29,738 | | | (12,777) | | | 36,010 | | Fixed assets, net | | | 8 | | | 25,581 | | | - | | | 25,589 | | Intangible assets, net | | | 1,823 | | | - | | | - | | | 1,823 | | Depreciation expense | | | 3 | | | 1,323 | | | - | | | 1,326 | | Amortization of intangible assets | | | 350 | | | - | | | - | | | 350 | | Year Ended June 30, 2016 (in thousands) | | iBio, Inc. | | iBio CDMO * | | Eliminations | | Total | | | | | | | | | | | | | | | | Revenues - external customers | | $ | 893 | | $ | 55 | | $ | - | | $ | 948 | | Revenues - intersegment | | | 158 | | | 324 | | | (482) | | | - | | Research and development | | | 2,984 | | | 501 | | | (329) | | | 3,156 | | General and administrative | | | 5,560 | | | 2,278 | | | (153) | | | 7,685 | | Operating loss | | | (7,493) | | | (2,400) | | | - | | | (9,893) | | Interest expense | | | - | | | (807) | | | - | | | (807) | | Interest and other income | | | 33 | | | 10 | | | - | | | 43 | | Consolidated net loss | | | (7,460) | | | (3,197) | | | - | | | (10,657) | | Total assets | | | 13,393 | | | 38,282 | | | (75) | | | 51,600 | | Fixed assets, net | | | 8 | | | 25,566 | | | - | | | 25,574 | | Intangible assets, net | | | 2,092 | | | - | | | - | | | 2,092 | | Depreciation expense | | | 4 | | | 573 | | | - | | | 577 | | Amortization of intangible assets | | | 363 | | | - | | | - | | | 363 | | * | iBio CDMO commenced operations in December 2015. |
|